TOUCAN

What this means for you

This application is over — abandoned 08 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

97822706

Mark type

Stylized text

Filed

03 Mar 2023

Abandoned

08 Mar 2024

Attorney of record

Rebecca Liebowitz

Goods and services

• Class 001 — Chemicals: Chemicals, enzymes, nucleic acid constructs and vectors for scientific and research use; nucleic acid constructs and vectors for use in the manufacture of nucleic acids; nucleic acid constructs and vectors for manufacturing viruses; nucleic acid constructs and vectors for use in scientific research
• Class 005 — Pharmaceuticals: Nucleic acid constructs for medical and veterinary purposes; nucleic acid constructs and vectors for use as prophylactic or therapeutic vaccines; nucleic acid constructs and vectors for the production of prophylactic or therapeutic vaccines; nucleic acid constructs and vectors for medical use; nucleic acid constructs and vectors for the production of therapeutic or prophylactic viruses; nucleic acid constructs and vectors for gene therapy; nucleic acid constructs and vectors for use in cell therapy; nucleic acid constructs and vectors for use in genome editing; nucleic acid constructs and vectors for use in therapy
• Class 009 — Scientific and electric apparatus: Apparatus and instruments for the manufacture and processing of nucleic acid constructs
• Class 040 — Treatment of materials: Treatment of nucleic acid constructs; manufacture of nucleic acid constructs; manufacture of nucleic acids; manufacture of viruses; manufacture of vectors; manufacture of medical and veterinary therapies, vaccines, prophylactics and counteragents; consultancy relating to the aforesaid services
• Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto; chemical and biological analysis and research services; research into nucleic acids and nucleic acid constructs; research and development into the creation of nucleic acid constructs; research, analysis, design and development relating to therapies, prophylactics and counteragents based on nucleic acid constructs; research and development in the fields of gene therapy and diagnostics; consultancy relating to the aforesaid services

Owner

• Touchlight IP Limited, Hampton, GB

Prosecution history

• 01 Apr 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 01 Apr 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 07 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 07 Dec 2023 — NON-FINAL ACTION E-MAILED
• 07 Dec 2023 — NON-FINAL ACTION WRITTEN
• 01 Dec 2023 — ASSIGNED TO EXAMINER
• 13 Nov 2023 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
• 13 Nov 2023 — ASSIGNED TO LIE
• 08 Jun 2023 — TEAS VOLUNTARY AMENDMENT RECEIVED
• 23 Mar 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 07 Mar 2023 — NEW APPLICATION ENTERED